Magnetar Financial’s Medicines Co MDCO Stock Holding History

Magnetar Financial’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,892,832	Closed	-$161M	–	728
2019 Q4	$161M	Buy	+1,892,832	New	+$126M	3.35%	10
2019 Q3	–	Sell	-20,000	Closed	-$729K	–	623
2019 Q2	$729K	Buy	+20,000	New	+$653K	0.01%	247
2013 Q3	–	Sell	-45,247	Closed	-$1.39M	–	535
2013 Q2	$1.39M	Buy	+45,247	New	+$1.51M	0.03%	197

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Magnetar Financial's MDCO Position: Q1 2020 in Review

Magnetar Financial sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,892,832 shares — an estimated $161M sold.

Magnetar Financial first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $161M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Magnetar Financial reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Magnetar Financial sold 1,892,832 Medicines Co shares in Q1 2020, an estimated $161M.
Magnetar Financial first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
Magnetar Financial's Medicines Co position peaked at $161M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Magnetar Financial's 13F filing for Q1 2020, filed 15 May 2020.